EUVIMEDOpdag EUVIMED
BeobachtungsstudieOpen access

Predicting Structural Progression‐Free Survival After Surgery for Medullary Thyroid Carcinoma

I Ros-Madrid, B Febrero iD, R P Cano-Mármol, P Segura, M Ferrer, J M Rodríguez

World Journal of Surgery · 2026

DOI: 10.1002/wjs.70524 ↗

At a glance

Beobachtungsstudie in World Journal of Surgery, 2026. Written by I Ros-Madrid and 5 co-authors. Institution: Endocrinology Service, Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain. Major MEDLINE topics: Thyroid Neoplasms, Thyroidectomy, Carcinoma, Neuroendocrine. 29 references. The full text is freely available in PubMed Central. Funded by: Instituto de Salud Carlos III.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Medullary thyroid cancer (MTC) is an aggressive tumor for which surgery is the only curative treatment. However, after surgery, some patients may experience persistence/recurrence. It is important to identify the prognostic factors that may affect structural disease‐free survival (SDFS), which may influence the follow‐up of our patients.

Objective

To assess SDFS in patients with MTC and related factors.

Methods

A retrospective observational study was conducted in a tertiary hospital including patients with MTC without distant metastases. The following variables were assessed: sex, age, heritability, type of surgery, calcitonin (Ct) and CEA, tumor size, stage, lymph nodes ratio (LNR), vascular invasion, high risk, structural disease, and SDFS. A descriptive and comparative univariate and multivariate analysis of SDFS was performed using SPSS version.29 and Cox regression, defining structural disease as the event. p < 0.05 was considered statistically significant.

Results

A total of 140 patients with a median age of 34 years were evaluated. Forty‐six percent ( n = 65) were male. Twenty‐two percent ( n = 31) had sporadic MTC, 75% ( n = 106) had MEN2a, and 2% ( n = 3) had MEN2b. The median calcitonin level was 182.5pg/mL and median follow‐up was 179.5 months. Structural disease occurred in 24% of patients ( n = 33). The variables that influenced the SDFS were as follows: sporadic CMT, older age, preoperative CEA, size, lymph node involvement, higher LNR, vascular invasion and high risk, and Ct levels > 150pg/mL at 6–12 months. In the multivariate analysis, age, LNR, T category, and postoperative Ct remained independent predictors.

Conclusion

The SDFS in MTC is significantly influenced by LNR, T category, and postoperative Ct levels at 6–12 months.

Subjects

MeSH terms (MEDLINE)

Thyroid NeoplasmsThyroidectomyCarcinoma, NeuroendocrineHumansRetrospective StudiesMaleFemaleAdultMiddle AgedPrognosisProgression-Free SurvivalNeoplasm Recurrence, LocalYoung AdultCalcitoninAgedAdolescentNeoplasm Staging

Author keywords

LNRMEN 2 patientsdisease‐free survivalmedullary thyroid cancerprognostic factors

Substances

Calcitonin

Authors and institutions

  • Endocrinology Service, Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain.
  • Instituto Murciano de Investigación Biosanitaria Pascual Parrilla (IMIB Pascual Parrilla), Murcia, Spain.
  • Endocrine Surgery Unit, General Surgery Service, Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain.
  • Deparment of Surgery, University of Murcia, Murcia, Spain.

ORCID profiles: B Febrero

Funding

  • Instituto de Salud Carlos III

Cite

APA

Ros-Madrid, I., Febrero, B., Cano-Mármol, R. P., Segura, P., Ferrer, M., & Rodríguez, J. M. (2026). Predicting Structural Progression‐Free Survival After Surgery for Medullary Thyroid Carcinoma. World Journal of Surgery. https://doi.org/10.1002/wjs.70524

Vancouver

Ros-Madrid I, Febrero B, Cano-Mármol RP, Segura P, Ferrer M, Rodríguez JM. Predicting Structural Progression‐Free Survival After Surgery for Medullary Thyroid Carcinoma. World Journal of Surgery. 2026. doi:10.1002/wjs.70524

BibTeX
@article{RosMadrid2026,
  author = {Ros-Madrid, I and Febrero, B and Cano-Mármol, R P and Segura, P and Ferrer, M and Rodríguez, J M},
  title = {Predicting Structural Progression‐Free Survival After Surgery for Medullary Thyroid Carcinoma},
  journal = {World Journal of Surgery},
  year = {2026},
  doi = {10.1002/wjs.70524}
}
Start for free →